MON-491 Persistent Isolated Hypophosphatemia after Intravenous Ferric Carboxymaltose Infusion in a Patient with Total Gastrectomy

Introduction: Intravenous ferric carboxymaltose infusion has been reported by the FDA to cause hypophosphatemia in 2.1% of patients, with transient low phosphorus level (<2mg/dL) observed in 27% of patients. We present a case of persistent hypophosphatemia where intravenous iron appeared to be a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bailey, Rosemary, Del Castillo, Ma. Dolores, Muppavarapu, Sangeetha, Siegel, Richard, Vercollone, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Bone and Mineral Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550829/
http://dx.doi.org/10.1210/js.2019-MON-491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550829/
http://dx.doi.org/10.1210/js.2019-MON-491

Ejemplares similares